Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.20%)
As of: Sep 4, 2026 · 3:14 PM EDT

Valneva SE (VALN) Accumulated Expenses (2020 - 2026)

Valneva SE (VALN) posted Accumulated Expenses of $14.7 million for Q4 2025, up 5.07% sequentially from $14.0 million in Q4 2024, and up 5.07% YoY from $14.0 million in Q4 2024.

Analysis

Valneva SE (VALN) Accumulated Expenses (2020 - 2026) Analysis & Trends

Valneva SE has reported Accumulated Expenses for 6 years, with the latest figure at $14.7 million in Q4 2025.

  • Quarterly Accumulated Expenses rose 5.07% year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (up 5.07% YoY) and the FY2025 annual result came in at $14.7 million, up 3.73% from the prior year.
  • Accumulated Expenses climbed to $14.7 million in Q4 2025 per VALN's latest filing, from $14.0 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $14.7 million in Q4 2025 and troughed at $10.9 million in Q2 2024.
  • A 5-year average of $12.3 million and a median of $11.6 million in 2021 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2024: Accumulated Expenses decreased 4.84% in 2022, then rose 20.37% in 2024.
  • Over 5 years, Accumulated Expenses stood at $11.6 million in 2021, then slipped by 4.84% to $11.0 million in 2022, then climbed by 5.82% to $11.6 million in 2023, then climbed by 20.37% to $14.0 million in 2024, then increased by 5.07% to $14.7 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $14.7 million, $14.0 million, and $10.9 million for Q4 2025, Q4 2024, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Valneva SE 580.64 Mn 439.38 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.98 Mn
Mar 31, 2026 26.10 Mn
Dec 31, 2025 22.76 Mn
Sep 30, 2025 21.86 Mn
Jun 30, 2025 20.99 Mn
Mar 31, 2025 21.50 Mn
Dec 31, 2024 20.79 Mn
Sep 30, 2024 20.12 Mn
Jun 30, 2024 18.67 Mn
Mar 31, 2024 18.76 Mn
Dec 31, 2023 17.44 Mn
Sep 30, 2023 15.78 Mn
Jun 30, 2023 17.98 Mn
Mar 31, 2023 17.04 Mn
Dec 31, 2022 16.06 Mn
Sep 30, 2022 16.17 Mn
Jun 30, 2022 16.22 Mn
Dec 31, 2021 19.73 Mn
Dec 31, 2020 15.70 Mn